Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation.

The impact of hepatitis C virus-positive donor kidneys on patient survival has not been analyzed in a national study. This study analyzed 20,111 adult (age, > or =16 yr) recipients having solitary cadaveric kidney transplants from adult donors with valid donor hepatitis C serologies from July 1, 1994, to June 30, 1998, in an historical cohort study (the 2000 United States Kidney Data System) of patient survival. Analysis was by the Cox proportional hazards models, which corrected for characteristics thought to affect outcomes. Of 484 kidneys positive for hepatitis C virus serology, 165 (34%) were given to recipients with confirmed negative hepatitis C serologies. Unadjusted 3-yr patient survival was 93% in all recipients of donor hepatitis C-negative kidneys versus 85% in all recipients of donor hepatitis C-positive kidneys (P = 0.01). Among hepatitis C-positive recipients, those who received hepatitis C-positive kidneys had worse survival than recipients of hepatitis C-negative kidneys. Among elderly hepatitis C-negative recipients, those who received hepatitis C-positive kidneys also had worse survival; in fact, all recipients of donor hepatitis C-positive kidneys had increased risk of mortality (P = 0.028). There were no significant interactions between donor hepatitis C positivity and either recipient hepatitis C positivity or older recipient age. The use of hepatitis C-positive kidneys in recipients who were hepatitis C-negative was fairly common and contrary to some current recommendations. Recipients of donor hepatitis C-positive kidneys were at independently increased risk of mortality, with no evidence that any subgroups were less affected.

[1]  P. Marcellin,et al.  Hepatitis C virus infection in anti-HIV positive and negative French homosexual men with chronic hepatitis: comparison of second- and third-generation anti-HCV testing. , 2008, Liver.

[2]  A. Bruchfeld,et al.  Hepatitis C Infection, Time in Renal-Replacement Therapy, and Outcome after Kidney Transplantation , 2004, Transplantation.

[3]  S. Natov,et al.  Management of Hepatitis C Infection in Renal Transplant Recipients , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  Arturo Pereira,et al.  The first case of HCV infection detected before seroconversion in blood donors tested by HCV core antigen ELISA , 2002, Transfusion.

[5]  A. Kirk,et al.  Effect of Donor Factors on Early Graft Survival in Adult Cadaveric Renal Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  H. Meier‐Kriesche,et al.  Death after graft loss: a novel endpoint for renal transplantation. , 2001, Transplantation proceedings.

[7]  C. Ponticelli,et al.  Hepatitis C virus infection and renal transplantation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  M. Charlton.  Hepatitis C Infection in Liver Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  L. Agodoa,et al.  The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. , 2001, Journal of nephrology.

[10]  B. Walker,et al.  Hepatitis C virus infection. , 2001, The New England journal of medicine.

[11]  A. Kirk,et al.  Hepatitis C Virus Seropositivity at the Time of Renal Transplantation in the United States: Associated Factors and Patient Survival , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  M. Joffe,et al.  Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. , 2001, The New England journal of medicine.

[13]  R. Wolfe,et al.  Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. , 2001, Journal of the American Society of Nephrology : JASN.

[14]  J. Morales,et al.  Use of kidneys from anti-HCV positive donors. , 2001, Transplantation proceedings.

[15]  W. Maley,et al.  Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors , 2000, Clinical transplantation.

[16]  A. Collins,et al.  Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. , 2000, American Journal of Kidney Diseases.

[17]  F. Delmonico,et al.  IMPACT OF POSITIVE HEPATITIS B AND C VIRUS DONOR SEROLOGY ON HEART AND KIDNEY ALLOGRAFT RECIPIENTS.: Abstract# 626 , 2000 .

[18]  B. Kasiske,et al.  Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[19]  N. Powe,et al.  Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. , 2000, Journal of the American Society of Nephrology : JASN.

[20]  A. Hartmann,et al.  [Cardiovascular disease after kidney transplantation]. , 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[21]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[22]  R. Foley,et al.  Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003 , 2022 .

[23]  P Coriat,et al.  Impact of hepatitis B and C virus on kidney transplantation outcome , 1999, Hepatology.

[24]  C. Schmid,et al.  Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  P. Landais,et al.  Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. , 1998, Transplantation.

[26]  A. Levey,et al.  Hepatitis C virus infection in dialysis and renal transplantation. , 1997, Kidney international.

[27]  C. Schmid,et al.  Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. , 1997, Transplantation.

[28]  C. Ponticelli,et al.  Increased detection of antibody to hepatitis C virus in renal transplant patients by third-generation assays. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  C. Legendre,et al.  Long-term outcome of hepatitis C infection after liver transplantation. , 1996, The New England journal of medicine.

[30]  Heneghan Ma.  Long-term outcome of hepatitis C infection after liver transplantation. , 1996 .

[31]  R. Rubin,et al.  Hepatitis C virus and organ transplantation. , 1996, Transplantation.

[32]  J. Morales,et al.  Should hepatitis C positive donors be accepted for renal transplantation? , 1996, Current opinion in nephrology and hypertension.

[33]  A. Levey,et al.  THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION , 1995, Transplantation.

[34]  C. Schmid,et al.  A controlled study of hepatitis C transmission by organ transplantation , 1995, The Lancet.

[35]  C. Schmid,et al.  Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. , 1994, Kidney international.

[36]  B. Kiberd.  Should hepatitis C-infected kidneys be transplanted in the United States? , 1994, Transplantation.

[37]  R. Mendez,et al.  HCV+ donors: should they be used for organ transplantation? , 1993, Transplantation proceedings.

[38]  Helen H. Lee,et al.  HEPATITIS C IS A POOR PROGNOSTIC INDICATOR IN BLACK KIDNEY TRANSPLANT RECIPIENTS , 1993, Transplantation.

[39]  R. Mendez,et al.  Expanding organ availability by using hepatitis C antibody positive donors. , 1993, Transplantation proceedings.

[40]  J. Lake,et al.  Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. , 1993, Transplantation.

[41]  A. Levey,et al.  Liver disease and HCV infection after transplantation of organs from hepatitis C antibody positive donors. , 1993, Transplantation proceedings.

[42]  E. Schiff,et al.  Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease , 1992, Annals of Internal Medicine.

[43]  A. Levey,et al.  Transmission of hepatitis C virus by organ transplantation. , 1991, The New England journal of medicine.

[44]  W. Mcdonnell.  Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, et al., Ann Intern Med 1992;117:1705–1709 , 1993 .